In a common AD mouse model where mice express the double transgenic APP/PS1 (chimeric mouse or human APP/human presenilin 1 [76]), the inhibition of TLR2 reduces glial cell reactivity, reduces Aβ, and improves cognitive function [77]. The gene discussed is APP; the disease is Alzheimer disease.